Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia-Reference-Cited by-同舟云学术

Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia

Published:2019-05 Issue:5 Volume:78 Page:393-401
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Piñana José Luis,Giménez Estela,Gómez María Dolores,Pérez Ariadna,González Eva María,Vinuesa Víctor,Hernández-Boluda Juan Carlos,Montoro Juan,Salavert Miguel,Tormo Mar,Amat Paula,Moles Paula,Carretero Carlos,Balaguer-Roselló Aitana,Sanz Jaime,Sanz Guillermo,Solano Carlos,Navarro David

Funder

Fondo de Investigaciones Sanitarias

Carlos III Health Institute

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference39 articles.

1. Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices;Erard;Clin Infect Dis,2015

2. Cytomegalovirus pneumonia in hematopoietic stem cell recipients;Travi;J Intensive Care Med,2014

3. An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation;Pérez Romero;Futur Virol,2015

4. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials;Ljungman;Clin Infect Dis,2017

5. Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation;Crawford;Chest,1988

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

2. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

3. Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and Standardization;Clinical Infectious Diseases;2024-07-29

4. The plasma viral communities associate with clinical profiles in a large-scale haematological patients cohort;Microbiome;2024-07-23

5. Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum;Clinical Infectious Diseases;2024-07-23